Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 676-681, February 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steen, R. G.
Right arrow Articles by Glickson, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steen, R. G.
Right arrow Articles by Glickson, J. D.

In Vivo 31P Nuclear Magnetic Resonance Spectroscopy of Subcutaneous 9L Gliosarcoma: Effects of Tumor Growth and Treatment with 1,3-Bis(2-chloroethyl)-1-nitrosourea on Tumor Bioenergetics and Histology1

R. Grant Steen, Rafael J. Tamargo, Kathy A. McGovern, S. Sunder Rajan, Henry Brem, Janna P. Wehrle and Jerry D. Glickson2

Departments of Radiology [R. G. S., K. A. M., S. S. R., J. P. W., J. D. G.], Neurological Surgery [R. J. T., H. B.], Oncology [H. B.], and Biological Chemistry [J. D. G.], The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

In vivo 31P nuclear magnetic resonance spectroscopy was used to examine the bioenergetics of the rat 9L gliosarcoma during untreated growth and in response to chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Tumor growth was associated with a decline in the phosphocreatine and nucleoside triphosphate resonances, consistent with an increase in tumor hypoxia during untreated growth. Following chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea (10 mg/kg), tumor levels of phosphocreatine and nucleoside triphosphate rebounded while the level of inorganic phosphate in the tumor declined. Histological comparison of treated and untreated tumor sections 4 days posttreatment showed that the treated tumor had a lower proportion of necrotic cells, a higher proportion of viable cells, and a 5-fold higher level of interstitial space than the control tumor.

1 Supported in part by USPHS Grants CA 39958 and CA 44703 from The NIH (to J. D. G.), NIH Grant NS 01508-01 and Grant IN-11W from the American Cancer Society (to H. B.), NRSA Traineeship CA 09199 from the NIH (to R. G. S.), and by the Association for Brain Tumor Research (to R. J. T.).

2 To whom requests for reprints should be addressed.

Received 8/10/87. Revised 10/26/87. Accepted 10/30/87.




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. Morvan and A. Demidem
Metabolomics by Proton Nuclear Magnetic Resonance Spectroscopy of the Response to Chloroethylnitrosourea Reveals Drug Efficacy and Tumor Adaptive Metabolic Pathways
Cancer Res., March 1, 2007; 67(5): 2150 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. M. Winter, H. Poptani, and N. Bansal
Effects of Chemotherapy by 1,3-Bis(2-chloroethyl)-1-nitrosourea on Single-Quantum- and Triple-Quantum-filtered 23Na and 31P Nuclear Magnetic Resonance of the Subcutaneously Implanted 9L Glioma
Cancer Res., March 1, 2001; 61(5): 2002 - 2007.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.